#53: Beta blockers in stable heart disease with Dr Sripal Bangalore

Nov 20, 2012 00:00 EST

Despite cautious and limited guideline endorsement, beta blockers are widely used in cardiovascular disease (and beyond). Why? Our guest Dr Sripal Bangalore discusses his research, which caused a stir in CV spheres but actually does not differ greatly from the guidelines. What is the evidence for beta blockers in CV disease? What are the next steps for this research? 

See also:

Beta blockers of no use in stable CAD patients

Bangalore S, Steg PHG, Deedwania P, et al. Beta blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 2012; 308:1340-1349. Abstract.

Dr Bangalore has served as an advisor or consultant for Daiichi-Sankyo and Boehringer Ingelheim.

For Dr Harrington's disclosures, click here.